Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Long Term Debt
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mainz Biomed N.V (MYNZ) Intangibles: 2021-2025

Historic Intangibles for Mainz Biomed N.V (MYNZ) over the last 1 years, with Jun 2025 value amounting to $4.0 million.

  • Mainz Biomed N.V's Intangibles rose 25.04% to $4.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $4.0 million, marking a year-over-year increase of 25.04%. This contributed to the annual value of $3.0 million for FY2024, which is 11.11% down from last year.
  • As of Q2 2025, Mainz Biomed N.V's Intangibles stood at $4.0 million, which was up 32.86% from $3.0 million recorded in Q4 2024.
  • Mainz Biomed N.V's Intangibles' 5-year high stood at $4.0 million during Q2 2025, with a 5-year trough of -$500,000 in Q1 2023.
  • Moreover, its 3-year median value for Intangibles was $3.4 million (2023), whereas its average is $2.9 million.
  • Its Intangibles has fluctuated over the past 5 years, first decreased by 11.69% in 2024, then rose by 25.04% in 2025.
  • Mainz Biomed N.V's Intangibles (Quarterly) stood at $1.2 million in 2021, then reached $3.4 million in 2023, then decreased by 11.11% to $3.0 million in 2024, then increased by 25.04% to $4.0 million in 2025.
  • Its Intangibles stands at $4.0 million for Q2 2025, versus $3.0 million for Q4 2024 and $3.2 million for Q2 2024.